CASI Pharma (CASI) Reports Q2 Loss of $0.52

CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.52). Revenue for the quarter came in at $3.98 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• ACI Worldwide exploring sale of billing division - Reuters
• Apple Music subscription price rises to $11.99 from $10.99